Neuroscience Research Australia (or NeuRA) is an independent medical research institute based in Sydney, Australia.
The Latest Bing News on:
Neuroscience Research Australia Research
- Molecular Signatures of Age-Related Macular Degeneration Identified
The discovery of molecular signatures of the incurable eye disease, age-related macular degeneration, could improve diagnosis and treatment.
- Genetic Clues to Age-Related Macular Degeneration Revealed
The discovery of new genetic signatures associated with age-related macular degeneration may lead to better diagnosis and treatment of the currently incurable vision disorder.
- Alleged Alzheimer’s research fraud won’t derail search for cure
Scientists say they won’t be deterred by claims that a major research paper into the causes of Alzheimer’s was fraudulent.
- Can ultra-processed foods affect cognitive performance?
They found that ultra-processed foods are linked to reduced language and executive function in older adults without chronic illness. They noted that reducing consumption of ultra-processed foods may ...
- Giving out flowers on TikTok: is this a ‘random act of kindness’ or just benevolent ageism?
She is Director of the UNSW Ageing Futures Institute, and affiliated with the ARC Centre of Excellence in Population Ageing and Neuroscience Research Australia. In June, 22-year-old Harrison ...
The Latest Google Headlines on:
Neuroscience Research Australia Research
The Latest Bing News on:
Neuroscience Research Australia Discovery
- Molecular Signatures of Age-Related Macular Degeneration Identified
The discovery of molecular signatures of the incurable eye disease, age-related macular degeneration, could improve diagnosis and treatment.
- Genetic Clues to Age-Related Macular Degeneration Revealed
The discovery of new genetic signatures associated with age-related macular degeneration may lead to better diagnosis and treatment of the currently incurable vision disorder.
- Alleged Alzheimer’s research fraud won’t derail search for cure
Australian experts ... with the findings presented in a research paper on the causes of Alzheimer’s. Alzheimer’s researchers have played down the discovery that key research from 16 years ...
- Field Trip Announces First Dosings In Phase I Clinical Study Of FT-104
First Dosings completed in Australia ... our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant ...
- Field Trip Announces First Dosings in Phase I Clinical Study of FT-104
Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip” or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today the first ...
